MedTrace Logo

A Single Arm Study of Traditional Chinese Medicine for Plasma Cell Mastitis

NCT05530226 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-09-07

No results posted yet for this study

Summary

This is a single-center, single-arm, open-label trial evaluating the efficacy and safety of traditional Chinese medicine for plasma cell mastitis.

Conditions

  • Plasma Cell Mastitis

Interventions

DRUG

Traditional Chinese medicine

Traditional Chinese medicine, oral administration, twice daily

Sponsors & Collaborators

  • Shengjing Hospital

    lead OTHER

Principal Investigators

  • Caigang Liu · Shengjing Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-10-31
Completion
2023-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05530226 on ClinicalTrials.gov